Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Algen Bio is revolutionizing therapeutic drug discovery by leveraging advanced CRISPR gene-modulation and AI. Their proprietary AlgenCRISPR system enables precise gene modulation, powering the…

Algen Bio is revolutionizing therapeutic drug discovery by leveraging advanced CRISPR gene-modulation and AI. Their proprietary AlgenCRISPR system enables precise gene modulation, powering the…
Founded: 2018
Headquarters: San Francisco, California
Focus: CRISPR gene-modulation + deep learning for therapeutic target discovery
Platforms: AlgenCRISPR and AlgenBrain
Employees (approx.): 14
Known investors: Sequoia Capital, Rebel Fund, Viking, Cota Capital, Draper, Illumina Accelerator, Y Combinator
Therapeutic target discovery for complex human diseases using functional genomics and machine learning.
2018
Biotechnology
8900000
Latest funding date and total funding amount provided in company snapshot.
“Backed by institutional and strategic investors including Sequoia Capital, Rebel Fund, Viking Global Investors, Cota Capital, Draper Associates, Illumina Accelerator, and Y Combinator.”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,400+
New This Week
| Company |
|---|